Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.
about
Gold nanoprobes for theranosticsCurrent understanding of interactions between nanoparticles and the immune systemEffects of the physicochemical properties of gold nanostructures on cellular internalizationAdsorption and Unfolding of a Single Protein Triggers Nanoparticle AggregationSafety of Nanoparticles in MedicineThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryCatalytic Properties and Biomedical Applications of Cerium Oxide NanoparticlesMetal Nanomaterial Toxicity Variations Within the Vascular SystemHigh resolution characterization of engineered nanomaterial dispersions in complex media using tunable resistive pulse sensing technologyProbing the mechanism of plasma protein adsorption on Au and Ag nanoparticles with FT-IR spectroscopy.Intracellular distribution of nontargeted quantum dots after natural uptake and microinjection.Immunological properties of gold nanoparticlesAction of Nanoparticles on Platelet Activation and Plasmatic CoagulationScavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles.Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics.Toxicity of pristine graphene in experiments in a chicken embryo model.Competitive adsorption of thiolated polyethylene glycol and mercaptopropionic acid on gold nanoparticles measured by physical characterization methods.The nano-plasma interface: Implications of the protein corona.In vivo particle tracking and photothermal ablation using plasmon-resonant gold nanostars.Quantifying spectral changes experienced by plasmonic nanoparticles in a cellular environment to inform biomedical nanoparticle designTransferrin coated nanoparticles: study of the bionano interface in human plasma.Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEffects of surface-modifying ligands on the colloidal stability of ZnO nanoparticle dispersions in in vitro cytotoxicity test media.Direct deposition of gas phase generated aerosol gold nanoparticles into biological fluids--corona formation and particle size shifts.Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.Physicochemical Characterization and Cytotoxicity Screening of a Novel Colloidal Nanogold-Based Phenytoin Conjugate.The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance thresholdSize-dependent cellular toxicity and uptake of commercial colloidal gold nanoparticles in DU-145 cells.Wide-field time-gated photoluminescence microscopy for fast ultrahigh-sensitivity imaging of photoluminescent probes.In situ measurement of bovine serum albumin interaction with gold nanospheres.Transcutaneous drug delivery by liposomes using fractional laser technology.Fractional laser-assisted percutaneous drug delivery via temperature-responsive liposomes.Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties.Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes.Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application.Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P2860
Q24629197-60C7CD43-15CD-4292-B999-3985AE4D7200Q26345204-C35673D6-E824-4DBF-ADAA-DF41C92B83D4Q26774279-ABD7F93F-F8F7-46C6-A78A-9648D9F57A8AQ27341824-4204944B-4938-481B-AA3A-EBAC26DD4569Q28083076-20842CB9-AD63-4D07-9DAC-36BF0BC4F65EQ28085280-AE0B6616-C77F-4241-84C9-6EE24AFACB92Q28383937-486993F0-0A9C-492F-84A1-EFF24D0C3899Q28394244-639AE178-A4BC-40E5-8037-61F0BA9ECC26Q28394762-9DF33FCB-3E97-436B-AB41-3BD816816114Q30378451-4BBD96F2-083D-4834-8D6C-1FE8D730FDC7Q31111393-F10A587E-D4B8-4A33-A287-ED3E85AFDB73Q33578950-163A2A13-862C-4EAD-BC06-33316021D138Q33600393-1133F932-6A7D-4433-A7B4-8A28E40D20D8Q33744219-DA7D94F6-3B8F-4A2A-A70F-C10AE738E059Q33975321-B88C61F5-BABA-44A0-858C-712C2FC5E00BQ34017288-A2B09B52-B9A0-4983-81D5-79B75FCA925AQ34025939-9EACB76F-89F1-4D86-9FB3-FE5DE75CB0B7Q34075280-F67F5A7A-74FC-4731-A83E-0C66BE7865ABQ34109805-986AED2B-4E90-4E68-A5EF-451319B505BDQ34122883-F5D23E34-B970-4230-B563-76192A2D5114Q34174188-A23934BC-3EC4-4625-B779-01EB42469921Q34182490-D84CDF33-0175-43A2-B49F-B545A9CDD0AEQ34351046-61F57865-4FDF-4D82-962A-753E7030B4C8Q34634591-60644983-D56D-44E1-AD04-90FCB6C13494Q34787957-1CC6CC27-E538-4BCF-9B8D-315554BFD8B6Q35005100-0EF8779A-FD30-4A75-A118-ED6AA2680577Q35703091-DF3DE4E3-A461-418E-A071-1C5D0E358C57Q35763882-20B73516-A660-4508-A916-05D17CFF0000Q35917005-5CD968D3-CDF7-4E27-947B-909F8AF5DEC0Q35978871-4BE665BD-8A8D-41F4-9A8A-22A2E531E16EQ35979605-646C7A2E-E179-41E3-BFD1-1C97FD90C16AQ36041548-7C16F0A1-2E59-474C-9231-C40783FC3FB6Q36044253-536B177D-8293-4954-8211-92099B4919F3Q36227719-6BAACFBF-8C13-4101-9194-DBD32C94CCC2Q36301922-22120E63-28A7-49B5-9AC3-9303FAEBD5ECQ36403660-E9AC4397-4F88-464B-9F17-F7A7D44271B8Q36472643-A7CB9112-A9E0-44F8-A4A8-2C6A7848C863Q36608192-F969BAE4-54CE-4C2C-82DC-3AC23A24246DQ36617753-31AE79F1-A48B-40B6-AE7D-E5F08EAB93AEQ36933043-AD9A8DC2-B6B9-452D-A0F0-15BFCE6F5F2B
P2860
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Interaction of colloidal gold ...... asma protein binding profiles.
@en
type
label
Interaction of colloidal gold ...... asma protein binding profiles.
@en
prefLabel
Interaction of colloidal gold ...... asma protein binding profiles.
@en
P2093
P2860
P1476
Interaction of colloidal gold ...... asma protein binding profiles.
@en
P2093
Anil K Patri
Barry W Neun
Jeffrey D Clogston
Jennifer B Hall
Jiwen Zheng
Marina A Dobrovolskaia
Nader Ayub
Parag Aggarwal
Scott E McNeil
P2860
P304
P356
10.1016/J.NANO.2008.08.001
P577
2008-12-13T00:00:00Z